Yipinhong Pharmaceutical (USA)

Yipinhong Pharmaceutical (USA) develops and commercializes specialized pharmaceutical products, primarily targeting pediatric and chronic diseases. The company integrates traditional Chinese medicine principles with modern biotechnology, producing diverse finished formulations like tablets, capsules, liquid orals, and injectables. This approach underpins its pipeline, designed for targeted therapeutic solutions across various health conditions.

The company was founded in 2002 by Han Xiong Li, who envisioned addressing unmet medical needs through innovative pharmaceutical treatments. Li established the enterprise with an insight into harmonizing traditional medical wisdom with contemporary scientific research. This foundational principle aimed to develop effective, accessible medicines, paving the way for product diversification.

Yipinhong Pharmaceutical primarily serves patients with pediatric respiratory infections and various chronic conditions, offering therapeutic and supportive care solutions. Its overarching vision is to expand its international reach, delivering specialized pharmaceutical offerings that advance global public health and open new treatment pathways for complex medical challenges.